Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-20T08:45:26.410Z Has data issue: false hasContentIssue false

What's Missing? Discussing Stem Cell Translational Research in Educational Information on Stem Cell “Tourism”

Published online by Cambridge University Press:  01 January 2021

Extract

Stem cell tourism is a form of medical tourism in which patients travel to receive unproven or untested stem cell-based interventions for many different diseases and conditions. A few studies indicate that patients and the public have several reasons for seeking these treatments for themselves or for their loved ones. Among these are the feeling of not having any other clinical options left, distrust of or frustration with their home country’s health care system, and a perception that their home country has a burdensome or sluggish regulatory system for the approval of novel stem cell therapies. These last two viewpoints may contribute to a certain sense of distrust of regulatory agencies governing the conduct of clinical research, and perhaps the perception of a health care system that seems unresponsive to the needs of patients suffering from severe conditions.

Type
Symposium
Copyright
Copyright © American Society of Law, Medicine and Ethics 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rachul, C., “‘What Have I Got to Lose?’ An Analysis of Stem Cell Therapy Patients' Blogs,” Health Law Review 20, no. 1 (2011): 5–12; Chen, H. and Gottweis, H., “Stem Cell Treatments in China: Rethinking the Patient Role in the Global Bio-Economy,” Bioethics (2011); Ryan, K. A. Sanders, A. M. Wang, D. D., and Levine, A. D., “Tracking the Rise of Stem Cell Tourism,” Regenerative Medicine 5, no. 1 (2010): 2733.Google Scholar
Zarzeczny, A. and Caulfield, T., “Stem Cell Tourism and Doctors' Duties to Minors,” American Journal of Bioethics 10, no. 5 (2010): 3–15; Zarzeczny, A. Rachul, C., and Caulfield, T., “The Phenomenon of Stem Cell Tourism,” in Atala, A., ed., Progenitor and Stem Cell Technologies and Therapies: Principles and Issues, vol. 1 (Cambridge, U.K.: Woodhead Publishing, 2012): at 206–233; Regenberg, A. Hutchinson, L. Schanker, B., and Mathews, D., “Medicine on the Fringe: Stem Cell-Based Interventions in Advance of Evidence,” Stem Cells 27, no. 9 (2009): 23122319; Lindvall, O. and Hyun, I., “Medical Innovation Versus Stem Cell Tourism,” Science 324, 5935 (2009): 1664–1665; Sipp, D., “Hope Alone Is Not an Outcome: Why Regulations Make Sense for the Global Stem Cell Industry,” American Journal of Bioethics 10, no. 5 (2010): 33–34; Caplan, A. and Levine, B., “Hope, Hype and Help: Ethically Assessing the Growing Market In Stem Cell Therapies,” American Journal of Bioethics 10, no. 5 (2010): 2425; Foster, S., “The Role of Patients and Patient Advocacy Groups in Educating Patients on the Importance of Legitimate Scientific Research,” American Journal of Bioethics 10, no. 5 (2010): 49.Google Scholar
Song, P., “Biotech Pilgrims and the Transnational Quest for Stem Cell Cures,” Medical Anthropology 29, no. 4 (2010): 384404.CrossRefGoogle Scholar
Sipp, D., “Stem Cell Pseudomedicine: Calling A Spade A Spade,” September 5, 2011, Blog: Stem Cell Treatment Monitor, available at <http://sctmonitor.blogspot.com/2011/09/stem-cell-pseudomedicine-calling-spade.html> (last visited January 16, 2013); Zarzeczny, A. Rachul, C. Nisbet, M., and Caulfield, T., “Stem Cell Clinics in The News,” Nature Biotechnology 28, no. 12 (2010): 12431246; Ryan, et al., supra note 1.Google Scholar
See Lindvall, and Hyun, , supra note 2.Google Scholar
See Regenberg, et al., supra note 2; Lau, D. Ogbogu, U. Taylor, B. Stafinski, T. Menon, D., and Caulfield, T., “Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine,” Cell Stem Cell 3, no. 6 (2008): 591594.Google Scholar
See Lau, et al., supra note 6; Regenberg, et al., supra note 2; Ryan, et al., supra note 1.Google Scholar
See Lau, et al., supra note 6; Regenberg, et al., supra note 2; Taylor, P. Barker, R. Blume, K. Cattaneo, E. Colman, A., and Deng, H. et al., “Patients Beware: Commercialized Stem Cell Treatments on the Web,” Cell Stem Cell 7, no. 1 (2010): 4349.Google Scholar
See Lau, et al., supra note 6.Google Scholar
See Zarzeczny, et al., supra note 4.Google Scholar
Amariglio, N. Hirshberg, A. Scheithauer, B.W. Cohen, Y. Loewenthal, R., and Trakhtenbrot, L. et al., “Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient,” PLoS Medicine 6, no. 2 (2009): E10000029; Miller, N., “Stem Cell Therapy Sees Man “Infected” With Cancer,” November 22, 2009, WAToday, available at <http://www.watoday.com.au/national/stem-cell-therapy-sees-man-infected-with-cancer-20091123-itch.html> (last visited January 17, 2013).Google Scholar
Dobkin, B. Curt, A., and Guest, J., “Cellular Transplants in China: Observational Study from the Largest Human Experiment in Chronic Spinal Cord Injury,” Neurorehabilitation and Neural Repair 20, no. 1 (2006): 5–13; Barclay, E., “Stem-Cell Experts Raise Concerns about Medical Tourism,” The Lancet 373, no. 9667 (2009): 883884.Google Scholar
Thirabanjasak, D. Tantiwongse, K., and Thorner, P., “Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy,” Journal of the American Society of Nephrology 21, no. 7 (2010): 12181222.CrossRefGoogle Scholar
Vogel, G., “Authorities Shut Controversial German Stem Cell Clinic,” Science Insider, May 10, 2011, available at <http://news.sciencemag.org/scienceinsider/2011/05/authorities-shut-controversial-g.html?rss=1> (last visited January 17, 2013); Mendick, R. and Palmer, A., “Baby Death Scandal at Stem Cell Clinic Which Treats Hundreds of British Patients a Year,” October 23, 2010, The Telegraph, available at <http://www.telegraph.co.uk/news/worldnews/europe/germany/8082935/Baby-death-scandal-at-stem-cell-clinic-which-treats-hundreds-of-British-patients-a-year.html> (last visited January 17, 2013); Mendick, R. and Hall, A., “Europe's Largest Stem Cell Clinic Shut Down after Death of Baby,” May 8, 2011, The Telegraph, available at <http://www.telegraph.co.uk/news/worldnews/europe/germany/8500233/Europes-largest-stem-cell-clinic-shut-down-after-death-of-baby.html> (last visited January 17, 2013); Cyranoski, D., “Korean Deaths Spark Inquiry,” Nature 468, no. 7323 (2010): 485.Google Scholar
Cyranoksi, D., “Stem-Cell Therapy Faces More Scrutiny In China,” Nature 459, no. 7244 (2009): 146–147; Nature, “Stem-Cell Laws in China Fall Short,” Nature 467, no. 7316 (2010): 633; see Chen, and Gottweis, , supra note 1.Google Scholar
Stafford, N., “Germany Tightens Law on Stem Cell Treatments,” BMJ 339, (2009): b2967; see Vogel, , supra note 14.Google Scholar
See Stafford, , supra note 16.Google Scholar
Carrol, R., “Costa Rican Health Ministry Bans Experimental Stem Cell Treatment,” The Guardian, available at <http://www.guardian.co.uk/world/2010/jun/07/costa-rica-stem-cell-treatment> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
Than, K., “Hungary Detains 4 over Illegal Stem Cell Treatment,” Reuters, available at <http://www.reuters.com/article/2009/07/29/us-hungary-stemcell-idUSTRE56S4PR20090729?pageNumber=1&virtualBrandChannel=0> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
Sung-Sik, S. and Gwang-Lip, M., “RNL Bio Probed Over Stem Cell Treatments,” Korea Joongang Daily, available at <http://koreajoongangdaily.joinsmsn.com/news/article/article.aspx?aid=2930548> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
Yee, J., “Dominican Authorities Warn Stem Cell Treatments Are Illegal,” BioEdge, available at <http://www.bioedge.org/index.php/bioethics/bioethics_article/9559/> (last visited January 17, 2013); Dominican Today, “Stem Cell Treatments Illegal, Dominican Authorities Warn,” Dominican Today, available at <http://www.dominicantoday.com/dr/local/2011/5/24/39647/stem-cell-treatments-illegal-domincanauthorities-warn> (last visited January 17, 2013).+(last+visited+January+17,+2013);+Dominican+Today,+“Stem+Cell+Treatments+Illegal,+Dominican+Authorities+Warn,”+Dominican+Today,+available+at++(last+visited+January+17,+2013).>Google Scholar
Cyranoski, D., “China's Stem-Cell Rules Go Unheeded,” Nature 484, no. 7393 (2012): 149150.CrossRefGoogle Scholar
Ward, V., “Stem Cell Doctor Robert Trossel Struck Off Medical Register,” September 30, 2010, The Telegraph, available at <http://www.telegraph.co.uk/health/healthnews/8033130/Stem-cell-doctor-Robert-Trossel-struck-off-medical-register.html> (last visited January 17, 2013); State of Florida, Department of Health. Final Order No. DOH-11-473-ERO0MGA, File Date February 22, 2011, Case Number: 2010–14317.+(last+visited+January+17,+2013);+State+of+Florida,+Department+of+Health.+Final+Order+No.+DOH-11-473-ERO0MGA,+File+Date+February+22,+2011,+Case+Number:+2010–14317.>Google Scholar
Cyranoski, D., “FDA Challenges Stem-Cell Clinic,” Nature 466, no. 7309 (2010): 909; Lysaght, T. and Campbell, A., “Regulating Autologous Adult Stem Cells: The FDA Steps Up,” Cell Stem Cell 9, no. 5 (2011): 393–396; von Tigerstrom, B., “The Food and Drug Administration, Regenerative Sciences, and the Regulation of Autologous Stem Cell Therapies,” Food and Drug Law Journal 66 (2011): 479–506; Blevins, J., “Stem-Cell Therapy Feels Food and Drug Administration's Pinch,” April13, 2010, Denver Post, available at <http://www.denverpost.com/news/ci_14871656> (last visited January 17, 2013).Google Scholar
See Federal Bureau of Investigation, San Antonio Division, U.S. Attorney's Office(a), Press Release, Owner of Arizona Company Charged and Convicted of Introducing an Unapproved New Drug – Stem Cells – into Interstate Commerce (August 18, 2011), available at <http://www.fbi.gov/sanantonio/press-releases/2011/owner-of-arizona-company-charged-and-convicted-of-introducing-an-unapproved-new-drug-stem-cells-into-interstate-commerce> (last visited January 17, 2013); See Federal Bureau of Investigation, San Antonio Division, U.S. Attorney's Office(b), Federal Indictments Lead to Arrests in Stem Cell Case, Press Release, December 28, 2011, available at <http://www.fbi.gov/sanantonio/press-releases/2011/federal-indictments-lead-to-arrests-in-stem-cellcase> (last visited January 2, 2012). (last visited January 17, 2013); See Federal Bureau of Investigation, San Antonio Division, U.S. Attorney's Office(b), Federal Indictments Lead to Arrests in Stem Cell Case, Press Release, December 28, 2011, available at (last visited January 2, 2012).' href=https://scholar.google.com/scholar?q=See+Federal+Bureau+of+Investigation,+San+Antonio+Division,+U.S.+Attorney's+Office(a),+Press+Release,+Owner+of+Arizona+Company+Charged+and+Convicted+of+Introducing+an+Unapproved+New+Drug+–+Stem+Cells+–+into+Interstate+Commerce+(August+18,+2011),+available+at++(last+visited+January+17,+2013);+See+Federal+Bureau+of+Investigation,+San+Antonio+Division,+U.S.+Attorney's+Office(b),+Federal+Indictments+Lead+to+Arrests+in+Stem+Cell+Case,+Press+Release,+December+28,+2011,+available+at++(last+visited+January+2,+2012).>Google Scholar
Callaway, E., “American Scientist Arrested In Stem-Cell Clinic Sting,” 2011, Nature News blog, available at <http://blogs.nature.com/news/2011/12/american-scientist-arrested-in-stem-cell-clinic-sting.html> (last visited January 17, 2013); Furlow, B., “Arrests in the USA Over Unapproved Stem-Cell Therapies,” The Lancet Oncology 13, no. 2 (2012): 55.Google Scholar
Master, Z. and Ogbogu, U., “Stem Cell Tourism in the Era of Personalized Medicine: What We Know, and What We Need to Know,” Current Pharmacogenomics and Personalized Medicine 10, no. 2 (2012): 106110.CrossRefGoogle Scholar
International Society for Stem Cell Research (ISSCR), Patient Handbook on Stem Cell Therapies, December3, 2008, available at <http://www.isscr.org/clinical_trans/pdfs/ISSCRPatientHandbook.pdf> (last visited March 30, 2011).+(last+visited+March+30,+2011).>Google Scholar
International Society for Stem Cell Research (ISSCR), “A Closer Look at Stem Cells,” available at <http://www.closer-lookatstemcells.org//AM/Template.cfm?Section=Home1> (last visited April 4, 2012).+(last+visited+April+4,+2012).>Google Scholar
Australian Stem Cell Centre, “Stem Cell Therapies: Now and In The Future – The Australian Stem Cell Centre Patient Handbook,” 2009, available at <http://www.msnz.org.nz/Document.Doc?id=23> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
UKSCN, UKSCN Position Statement on Stem Cell Tourism, available at <http://www.uknscn.org/downloads/stem_cell_tourism.pdf> (last visited January 17, 2013); Stem Cell Network, “Stem Cell Hype and The Dangers Of Stem Cell ‘Tourism,’” available at <http://www.stemcellnetwork.ca/index.php?page=stem-cell-hype-and-the-dangers-of-stem-cell-tourism> (last visited January 17, 2013).+(last+visited+January+17,+2013);+Stem+Cell+Network,+“Stem+Cell+Hype+and+The+Dangers+Of+Stem+Cell+‘Tourism,’”+available+at++(last+visited+January+17,+2013).>Google Scholar
Parkinson Society Canada, Stem Cell Research and Parkinson's Disease, 2009, available at <http://www.parkinson.ca/atf/cf/%7B9EBD08A9-7886-4B2D-A1C4-A131E7096BF8%7D/stem%20cells%20-%20en.pdf> (last visited January 17, 2013); Australia New Zealand Spinal Cord Injury Network, Stem Cell Interventions for Spinal Cord Injury, 2009, available at <http://www.stemcellcentre.edu.au/site/DefaultSite/filesystem/documents/For%20the%20Public/ANZSCIN%20Stem%20Cell%20Interventions%20for%20Spinal%20Cord%20Injury.pdf> (last visited November 10, 2011); MS Society (U.K.), MS Society Scotland, MS Society Cymru, MS Society Northern Ireland, Stem Cell Therapies in MS, 2010, available at <http://www.mssociety.org.au/documents/Stem-CellBooklet.pdf> (last visited January 17, 2013). (last visited January 17, 2013); Australia New Zealand Spinal Cord Injury Network, Stem Cell Interventions for Spinal Cord Injury, 2009, available at (last visited November 10, 2011); MS Society (U.K.), MS Society Scotland, MS Society Cymru, MS Society Northern Ireland, Stem Cell Therapies in MS, 2010, available at (last visited January 17, 2013).' href=https://scholar.google.com/scholar?q=Parkinson+Society+Canada,+Stem+Cell+Research+and+Parkinson's+Disease,+2009,+available+at++(last+visited+January+17,+2013);+Australia+New+Zealand+Spinal+Cord+Injury+Network,+Stem+Cell+Interventions+for+Spinal+Cord+Injury,+2009,+available+at++(last+visited+November+10,+2011);+MS+Society+(U.K.),+MS+Society+Scotland,+MS+Society+Cymru,+MS+Society+Northern+Ireland,+Stem+Cell+Therapies+in+MS,+2010,+available+at++(last+visited+January+17,+2013).>Google Scholar
ALSUntangled Group, “ALSUntangled Update 4: Investigating the XCell-Center,” Amyotrophic Lateral Sclerosis 11, no. 3 (2010): 337338.Google Scholar
See Zarzeczny, and Caulfield, , supra note 2; Caulfield, T. Zarzeczny, A. and the Toronto Stem Cell Working Group, “Stem Cell Tourism and Canadian Family Physicians,” Canadian Family Physician 58, no. 4 (2012): 365368.Google Scholar
Master, Z. and Resnik, D. B., “Stem Cell Tourism and Scientific Responsibility,” EMBO Reports 12, no. 10 (2011): 992995.CrossRefGoogle Scholar
See Ryan, et al., supra note 1.Google Scholar
See Rachul, , supra note 1; Chen, and Gottweis, , supra note 1.Google Scholar
See Rachul, , supra note 1; Chen, and Gottweis, , supra note 1; Ryan, et al., supra note 1.Google Scholar
See Rachul, , supra note 1.Google Scholar
The quoted passage is from Blog #8 in Rachul, , supra note 1, but the quote is not cited in the paper.Google Scholar
The quoted passage is from Blog #12 in Rachul, , supra note 1, but the quote is not cited in the paper.Google Scholar
See Chen, and Gottweis, , supra note 1, at 11.Google Scholar
Kitzinger, J. and Williams, C., “Forecasting Science Futures: Legitimising Hope and Calming Fears in the Embryo Stem Cell Debate,” Social Science and Medicine 61, no. 3 (2005): 731740; Knowles, L. P., Stem Cell Hype and the Dangers Of Stem Cell ‘Tourism,’ 2009, Ethics White Paper for the Stem Cell Network, available at <http://www.stemcellnetwork.ca/uploads/File/whitepapers/Stem-Cell-Hype.pdf> (last visited January 17, 2013); Rachul, C. Zarzeczny, A. Bublea, T. and Caulfield, T., “Stem Cell Research in the News: More Than a Moral Status Debate,” Scripted 7, no. 2 (2010): 311–323; see Ryan, , supra note 1.CrossRefGoogle Scholar
The cover of this magazine can be found in Time Magazine, How the Coming Revolution in Stem Cells Could Save Your Life, February 9, 2009, available at <http://www.time.com/time/covers/0,16641,20090209,00.html> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
The cover of this magazine can be found in The Economist, “Cancer and Stem Cells: The Connection That Could Lead to a Cure,” September 13, 2008, available at <http://www.economist.com/printedition/2008-09-13> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
See Zarzeczny, et al., supra note 4.Google Scholar
See Chen, and Gottweis, , supra note 1, at 11.Google Scholar
International Society for Stem Cell Research (ISSCR), Guidelines for the Clinical Translation of Stem Cells, December 3, 2008, available at <http://www.isscr.org/clinical_trans/pdfs/ISSCRGLClinicalTrans.pdf> (last visited March 30, 2011); Rayment, E. A. and Williams, D. J., “Concise Review: Mind the Gap: Challenges in Characterizing and Quantifying Cell- and Tissue-Based Therapies for Clinical Translation,” Stem Cells 28, no. 5 (2010): 9961004.Google Scholar
Knight, A., “Systematic Reviews of Animal Experiments Demonstrate Poor Contribution Towards Human Healthcare,” Reviews on Recent Clinical Trials 3, no. 2 (2008): 8996.CrossRefGoogle Scholar
Sena, E. S. van der Worp, H. B. Bath, P. M. W. Howells, D. W., and Macleod, M. R., “Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy,” PLoS Biology 8, no. 3 (2010):e1000344; Weaver, J., “Animal Studies Paint Misleading Picture,” Scientific American, March 30, 2010, available at <http://www.scientificamerican.com/article.cfm?id=animal-studies-paint-misleading> (last visited Apr. 9, 2012).CrossRefGoogle Scholar
See Rayment, and Williams, , supra note 50.Google Scholar
Halme, D. and Kessler, D., “FDA Regulation of Stem-Cell– Based Therapies,” New England Journal of Medicine 355, no. 16 (2006): 17301735.Google Scholar
Glass, K. C. Weijer, C. Cournoyer, D. Lemmens, T. Palmour, R. M., and Shapiro, S. H. et al., “Structuring the Review of Human Genetics Protocols, Part III: Gene Therapy Studies,” IRB 21, no. 2 (1999): 19.CrossRefGoogle Scholar
Master, Z. McLeod, M., and Mendez, I., “Benefits, Risks and Ethical Considerations in Translation of Stem Cell Research to Clinical Applications in Parkinson's Disease,” Journal of Medical Ethics 33, no. 3 (2007): 169–173; Fink, D. W. Jr., “FDA Regulation of Stem Cell-Based Products,” Science 324, no. 5935 (2009): 11621163.Google Scholar
Wilson, J., “A History Lesson for Stem Cells,” Science 324, no. 5928 (2009): 727728.CrossRefGoogle Scholar
21 C.F.R. § 312.21; ClinicalTrials.gov, “Understanding Clinical Trials,” available at <http://clinicaltrials.gov/ct2/info/understand> (last visited January 17, 2013); Levine, R., Ethics and Regulation of Clinical Research (New Haven: Yale University Press, 1986): at 6.Google Scholar
21 C.F.R. § 312.21. Id.Google Scholar
See Levine, , supra note 58.Google Scholar
Food and Drug Administration, “Tissue and Tissue Product Questions and Answers,” available at <http://www.fda.gov/BiologicsBloodVaccines/TissueTissueProducts/default.htm> (last visited January 17, 2013); 21 C.F.R. § 1270; 21 C.F.R. § 1271.+(last+visited+January+17,+2013);+21+C.F.R.+§+1270;+21+C.F.R.+§+1271.>Google Scholar
Health Canada, “Biologics and Genetic Therapies Directorate Centres and Offices,” available at <http://www.hc-sc.gc.ca/ahc-asc/branch-dirgen/hpfb-dgpsa/bgtd-dpbtg/centre-bureau-eng.php> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
Canadian Institutes of Health Research, “Updated Guidelines for Human Pluripotent Stem Cell Research, June 30, 2010,” available at <http://www.cihr-irsc.gc.ca/e/42071.html> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
For example, see von Tigerstrom, B., “The Challenges Of Regulating Stem Cell-Based Products,” Trends in Biotechnology 26, no. 12 (2008): 653658; Tigerstrom, Von, supra note 25.CrossRefGoogle Scholar
Wadman, M., “The Bridge between Lab and Clinic,” Nature 468, no. 7326 (2010): 877); Reed, J. C. White, E. L. Aubé, J. Lindsley, C. Li, M. Sklar, L., and Schreiber, S., “The NIH's Role in Accelerating Translational Sciences,” Nature Biotechnology 30, no. 1 (2012): 16–19.Google Scholar
Pollack, A., “Geron Is Shutting Its Stem Cell Clinical Trial,” New York Times, November 14, 2011, available at <http://www.nytimes.com/2011/11/15/business/geron-is-shutting-down-its-stem-cell-clinical-trial.html> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
Prasad, V. Cifu, A., and Ioannidis, J. P. A., “Reversals of Established Medical Practices. Evidence to Abandon Ship,” JAMA 307, no. 1 (2012): 3738.CrossRefGoogle Scholar
Kaiser, J., “Embryonic Stem Cells Appear Safe, May Help Eye Disease,” Science Now, January 23, 2012, available at <http://news.sciencemag.org/sciencenow/2012/01/embryonic-stem-cells-appear-safe.html?ref=em&elq=e8ec8290ab0a4cc38cf5c72130ffdcad> (last visited January 17, 2013); Schwartz, S. D. Hubschman, J. P. Heilwell, G. Franco-Cardenas, V., and Pan, C. K. et al., “Embryonic Stem Cell Trials for Macular Degeneration: A Preliminary Report,” The Lancet 379, no. 9817 (2012): 713720.Google Scholar
Jung, H. and Hyun-Young, Y., “South Korea Back in Stem Cell Spotlight with New Treatment,” Reuters, 2011, available at <http://www.reuters.com/article/2011/07/07/us-korea-stemcell-idUSTRE76610C20110707> (last visited January 17, 2013); Reinberg, S., “Stem-Cell Trial Failed to Treat Heart Failure,” HealthDay, March 6, 2012, available at <http://consumer.healthday.com/Article.asp?AID=663058> (last visited January 17, 2013).+(last+visited+January+17,+2013);+Reinberg,+S.,+“Stem-Cell+Trial+Failed+to+Treat+Heart+Failure,”+HealthDay,+March+6,+2012,+available+at++(last+visited+January+17,+2013).>Google Scholar
Parke, S. and Illes, J., “In Delicate Balance: Stem Cells and Spinal Cord Injury Advocacy,” Stem Cell Reviews and Reports 7, no. 3 (2011): 657663.CrossRefGoogle Scholar
See Rachul, , supra note 1.Google Scholar
International Society for Stem Cell Research (ISSCR), “Top Ten Things to Know about Stem Cell Treatments,” at Fact #5, available at <http://www.closerlookatstemcells.org/Top_10_Stem_Cell_Treatment_Facts.htm> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
See Master, et al., supra note 56.Google Scholar
See International Society for Stem Cell Research (ISSCR), supra note 73 at Fact #6.Google Scholar
International Society for Stem Cell Research (ISSCR), “How Science Becomes Medicine,” available at <http://www.closer-lookatstemcells.org/How_Science_Becomes_Medicine.htm> (last visited October 22, 2011).+(last+visited+October+22,+2011).>Google Scholar
Id.; see International Society for Stem Cell Research, supra note 29, at 4.Google Scholar
See International Society for Stem Cell Research, supra note 73.Google Scholar
MS Society (U.K.) et al., supra note 33 at 13; International Society for Stem Cell Research (ISSCR), How Clinical Trials Work, available at <http://www.closerlookatstemcells.org/Clinical_Trials.htm> (last visited October 22, 2011); see International Society for Stem Cell Research, supra note 73; Australian Stem Cell Centre, Stem Cell Therapies: Now and in the Future. The Australian Stem Cell Centre Information Handbook, April 2011, available at <http://www.stemcellcentre.edu.au/For_the_Public/Patient/Handbook.aspx> (last visited April 10, 2012).+(last+visited+October+22,+2011);+see+International+Society+for+Stem+Cell+Research,+supra+note+73;+Australian+Stem+Cell+Centre,+Stem+Cell+Therapies:+Now+and+in+the+Future.+The+Australian+Stem+Cell+Centre+Information+Handbook,+April+2011,+available+at++(last+visited+April+10,+2012).>Google Scholar
See MS Society, supra note 33, at 13.Google Scholar
See Australian Stem Cell Centre, supra note 79.Google Scholar
See International Society for Stem Cell Research, supra note 79; MS Society, supra note 33, at 13; Australian Stem Cell Centre, supra note 79.Google Scholar
See International Society for Stem Cell Research, supra note 79.Google Scholar
See Australian Stem Cell Centre, supra note 79.Google Scholar
See MS Society, supra note 33, at 12.Google Scholar
See Master, et al., supra note 56.Google Scholar
Food and Drug Administration, FDA Seeks Injunction Against Colorado Manufacturer of Cultured Cell Product, FDA News Release, August 6, 2010, available at <http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm221656.htm> (last visited January 17, 2013); Cyranoski, , supra note 25; Lysaght, and Campbell, , supra note 25; Tigerstrom, Von, supra note 25; Blevins, , supra note 25.+(last+visited+January+17,+2013);+Cyranoski,+,+supra+note+25;+Lysaght,+and+Campbell,+,+supra+note+25;+Tigerstrom,+Von,+supra+note+25;+Blevins,+,+supra+note+25.>Google Scholar
See Lindvall, and Hyun, , supra note 2.Google Scholar
Id., at 1664.Google Scholar
See Master, and Resnik, , supra note 36.Google Scholar
Fox, S. and Fallows, D., “Internet Health Resources,” Pew Internet & American Life Project (2003), 1–35, available at <http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2054071> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
Baker, L. Wagner, T. H. Singer, S., and Bundorf, M. K., “Use of the Internet and E-mail for Health Care Information: Results From a National Survey,” JAMA 289, no. 18 (2003): 24002406.Google Scholar
Tuffrey, C. and Finlay, F., “Use of the Internet by Parents of Paediatric Outpatients,” Archives of Disease in Childhood 87, no. 6 (2002): 534536; Wainstein, B. K. Sterling-Levis, K. Baker, S. A. Taitz, J., and Brydon, M., “Use of the Internet by Parents of Paediatric Patients,” Journal of Paediatrics and Child Health 42, no. 9 (2006): 528–532.CrossRefGoogle Scholar
Diaz, J. A. Griffith, R. A. Ng, J. J. Reinert, S. E., and Friedmann, P. D. et al., “Patients' Use of the Internet for Medical Information,” Journal of General Internal Medicine 17, no. 3 (2002): 180185.CrossRefGoogle Scholar
Hesse, B. W. Nelson, D. E. Kreps, G. L. Croyle, R. T., and Arora, N. K. et al., “Trust and Sources of Health Information,” Archives of Internal Medicine 165, no. 22 (2005): 26182624.CrossRefGoogle Scholar
Di Pietro, N. C. Whiteley, L. Mizgalewicz, A., and Illes, J., “Treatment of Neurodevelopmental Disorders: Evidence, Advocacy, and the Internet,” Journal of Autism and Developmental Disorders 43, no. 1 (2012): 122133.CrossRefGoogle Scholar
Schillinger, D. Grumbach, K. Piette, J. Wang, F., and Osmond, D. et al., “Association of Health Literacy with Diabetes Outcomes,” JAMA 288, no. 4 (2002): 475–482; Janson, S. L. Fahy, J. V. Covington, J. K. Paul, S. M., and Gold, W. M. et al., “Effects of Individual Self-Management Education on Clinical, Biological, and Adherence Outcomes in Asthma,” American Journal of Medicine 115, no. 8 (2003): 620626; Wong, A. L. Harker, J. O. Lau, V. P. Shatzel, S., and Port, L. H., “Spanish Arthritis Empowerment Program: A Dissemination and Effectiveness Study,” Arthritis & Rheumatism 51, no. 3 (2004): 332–336; Nijsten, T. Rolstad, T. Feldman, S.R., and Stern, R. S., “Members of the National Psoriasis Foundation: More Extensive Disease and Better Informed about Treatment Options,” Archives of Dermatology 141, no. 1 (2005): 19–26; Nielsen, D. Ryg, J. Nissen, N. Nielsen, W., and Knold, B. et al., “Multidisciplinary Patient Education in Groups Increases Knowledge on Osteoporosis: A Randomized Controlled Trial,” Scandinavian Journal of Public Health 36, no. 4 (2008): 346–352; Emtner, M. Hedin, A. Andersson, M., and Janson, C., “Impact of Patient Characteristics, Education and Knowledge on Emergency Room Visits in Patients with Asthma and COPD: A Descriptive and Correlative Study,” BMC Pulmonary Medicine 9, (2009): 43; Makoul, G. Cameron, K. A. Baker, D. W. Francis, L., and Scholtens, D. et al., “A Multimedia Patient Education Program on Colorectal Cancer Screening Increases Knowledge and Willingness to Consider Screening Among Hispanic/Latino Patients,” Patient Education and Counseling 76, no. 2 (2009): 220–226; Surjadi, M. Torruellas, C. Ayala, C. Yee, H. F. Jr., and Khalili, M., “Formal Patient Education Improves Patient Knowledge of Hepatitis C in Vulnerable Populations,” Digestive Diseases and Sciences 56, no. 1 (2011): 213–219.Google Scholar
Durant, J. R. Evans, G. A., and Thomas, G. P., “The Public Understanding of Science,” Nature 340, no. 6228 (1989): 11–14; Evans, G. and Durant, T., “The Relationship Between Knowledge and Attitudes in the Public Understanding of Science in Britain,” Public Understanding of Science 4, no. 1 (1995): 5774; Thomas, G. and Durant, J., “Why Should We Promote The Public Understanding Of Science?” Science Literacy Papers 1, (1987): 1–14, available at <http://www.core.org.cn/NR/rdonlyres/Science-Technology-and-Society/STS-014Spring-2006/2737FE74-34D6-4A16-A7DD-95F0FBE60BA0/0/durant_promote.pdf> (last visited May 14, 2011).Google Scholar
Mooney, C., Do Scientists Understand The Public? (Cambridge: American Academy of Arts and Sciences, 2010), available at <http://www.amacad.org/pdfs/scientistsUnderstand.pdf> (last visited January 17, 2013); Nisbet, M. C. and Goidel, R. K., “Understanding Citizen Perception of Science Controversy: Bridging the Ethnographic-Survey Research Divide,” Public Understanding of Science 16, no. 4 (2007): 421–440; Priest, S. H., “Misplaced Faith: Communication Variables as Predictors of Encouragement for Biotechnology Development,” Science Communication 23, no. 2 (2001): 97–110; Siegrist, M., “The Influence of Trust and Perceptions of Risks and Benefits on the Acceptance of Gene Technology,” Risk Analysis 20, no. 2 (2000): 195–203; Siegrist, M. and Cvetkovich, G., “Perception of Hazards: The Role of Social Trust and Knowledge,” Risk Analysis 20, no. 5 (2000): 713–719; Turney, J., “Public Understanding of Science,” The Lancet 347, no. 9008 (1996): 10871090; Ziman, J., “Public Understanding of Science,” Science, Technology, and Human Values 16, no. 1 (1991): 99–105; Priest, S. H. Bonfadelli, H., and Rusanen, M., “The ‘Trust Gap’ Hypothesis: Predicting Support for Biotechnology Across National Cultures as a Function of Trust in Actors,” Risk Analysis 23, no. 4 (2003): 751–766; Critchley, C. R., “Public Opinion and Trust in Scientists: The Role of the Research Context, and the Perceived Motivation of Stem Cell Researchers,” Public Understanding of Science 17, no. 3 (2008): 309–327; Liu, H. and Priest, S., “Understanding Public Support for Stem Cell Research: Media Communication, Interpersonal Communication and Trust in Key Actors,” Public Understanding of Science 18, no. 6 (2009): 704–718.Google Scholar
Wellcome Trust, “Information And Attitudes: Consulting the Public about Biomedical Science,” 2005, available at <http://www.wellcome.ac.uk/About-us/Publications/Reports/Public-engagement/WTX026430.htm> (last visited January 17, 2013).+(last+visited+January+17,+2013).>Google Scholar
See Rachul, , supra note 1; Murdoch, C. and Scott, C., “Stem Cell Tourism and the Power of Hope,” American Journal of Bioethics 10, no. 5 (2010): 16–23; Kwon, B. K. Ghag, A. Dvorak, M. F. Tetzlaf, W., and Illes, J., “Expectation of Benefit and Tolerance to Risk of Individuals with Spinal Cord Injury Regarding Potential Participation in Clinical Trials,” Journal of Neurotrauma 29, no. 18 (2012): 27272737.Google Scholar
Einsiedel, E. and Adamson, H., “Stem Cell Tourism and Future Stem Cell Tourists: Policy and Ethical Implications,” Developing World Bioethics 12, no. 1 (2012): 3544, at 35.CrossRefGoogle Scholar
In recognition of these and other potential challenges, we have designed a new public outreach initiative with the support of the Canadian Stem Cell Network. This initiative will produce a patient handbook that will be widely disseminated, including to the organizations included in our study examining online educational information on stem cell tourism, discussed above.Google Scholar
See Caulfield, et al., supra note 35; Levine, A. D. and Wolf, L. E., “The Roles and Responsibilities of Physicians in Patients' Decisions about Unproven Stem Cell Therapies,” Journal of Law, Medicine & Ethics 40, no. 1 (2012): 122134.Google Scholar
Master, Z. and Resnik, D. B., “Hype and Public Trust in Science,” Science and Engineering Ethics (2011).CrossRefGoogle Scholar
See Master, and Resnik, , supra note 36.Google Scholar